FDA Approves First mRNA Flu Vaccine For Older Adults

"Flu remains a significant public health challenge, and mFLUSIVA provides an important new option for America's seniors. This approval also reflects the ongoing potential of our mRNA platform,” Modern...

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。